171 related articles for article (PubMed ID: 37492584)
21. Sarcoid-like Reactions to Immune Checkpoint Inhibitors.
Torrecilla-Vall-Llossera C; Jucglà Serra A; Molinero Caturla J; Moreno-Vílchez C; Penín Mosquera RM; Marcoval Caus J
Actas Dermosifiliogr; 2024 Jan; 115(1):80-83. PubMed ID: 37482293
[TBL] [Abstract][Full Text] [Related]
22. Association of immune-related adverse events with the outcomes of immune checkpoint inhibitors in patients with dMMR/MSI-H metastatic colorectal cancer.
Nasca V; Barretta F; Corti F; Lonardi S; Niger M; Elez ME; Fakih M; Jayachandran P; Shah AT; Salati M; Fenocchio E; Salvatore L; Cremolini C; Ros J; Ambrosini M; Mazzoli G; Intini R; Overman MJ; Miceli R; Pietrantonio F
J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36593068
[TBL] [Abstract][Full Text] [Related]
23. Severe necrotizing myositis associated with long term anti-neoplastic efficacy following nivolumab plus ipilimumab combination therapy.
Tauber M; Cohen R; Laly P; Josselin L; André T; Mekinian A
Clin Rheumatol; 2019 Feb; 38(2):601-602. PubMed ID: 30456528
[TBL] [Abstract][Full Text] [Related]
24. Prediction of response to immune checkpoint blockade in patients with metastatic colorectal cancer with microsatellite instability.
Ratovomanana T; Nicolle R; Cohen R; Diehl A; Siret A; Letourneur Q; Buhard O; Perrier A; Guillerm E; Coulet F; Cervera P; Benusiglio P; Labrèche K; Colle R; Collura A; Despras E; Le Rouzic P; Renaud F; Cros J; Alentorn A; Touat M; Ayadi M; Bourgoin P; Prunier C; Tournigand C; Fouchardière C; Tougeron D; Jonchère V; Bennouna J; de Reynies A; Fléjou JF; Svrcek M; André T; Duval A
Ann Oncol; 2023 Aug; 34(8):703-713. PubMed ID: 37269904
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of immune checkpoint inhibitors for metastatic colorectal cancer with microsatellite instability in second or latter line using synthetic control arms: A non-randomised evaluation.
Cohen R; Raeisi M; Chibaudel B; Yoshino T; Shi Q; Zalcberg JR; Adams R; Cremolini C; Grothey A; Mayer RJ; Van Cutsem E; Tabernero J; Bando H; Misumi T; Overman MJ; André T; de Gramont A
Eur J Cancer; 2024 Mar; 199():113537. PubMed ID: 38241818
[TBL] [Abstract][Full Text] [Related]
26. Usefulness of endobronchial ultrasound-guided transbronchial needle aspiration in distinguishing sarcoidosis from recurrent cancer in patients with lymphadenopathy after surgery.
Minami D; Takigawa N; Hayakawa H; Mizuta M; Kudo K; Uchida K; Ichihara E; Sato A; Hotta K; Tabata M; Tanimoto M; Kiura K
Jpn J Clin Oncol; 2013 Nov; 43(11):1110-4. PubMed ID: 23997237
[TBL] [Abstract][Full Text] [Related]
27. Delayed onset of neurosarcoidosis after concurrent ipilimumab/nivolumab therapy.
Tan I; Malinzak M; Salama AKS
J Immunother Cancer; 2018 Jul; 6(1):77. PubMed ID: 30064495
[TBL] [Abstract][Full Text] [Related]
28. Granulomatous/sarcoid-like lesions associated with checkpoint inhibitors: a marker of therapy response in a subset of melanoma patients.
Tetzlaff MT; Nelson KC; Diab A; Staerkel GA; Nagarajan P; Torres-Cabala CA; Chasen BA; Wargo JA; Prieto VG; Amaria RN; Curry JL
J Immunother Cancer; 2018 Feb; 6(1):14. PubMed ID: 29433571
[TBL] [Abstract][Full Text] [Related]
29. Complete Pathological Response After Neoadjuvant Short-Course Immunotherapy with Ipilimumab and Nivolumab in Locally Advanced MSI-H/dMMR Rectal Cancer.
Trojan J; Stintzing S; Haase O; Koch C; Ziegler P; Demes M; Jelas I
Oncologist; 2021 Dec; 26(12):e2110-e2114. PubMed ID: 34431576
[TBL] [Abstract][Full Text] [Related]
30. Nivolumab plus low-dose ipilimumab in previously treated patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: 4-year follow-up from CheckMate 142.
André T; Lonardi S; Wong KYM; Lenz HJ; Gelsomino F; Aglietta M; Morse MA; Van Cutsem E; McDermott R; Hill A; Sawyer MB; Hendlisz A; Neyns B; Abdullaev S; Memaj A; Lei M; Dixon M; Kopetz S; Overman MJ
Ann Oncol; 2022 Oct; 33(10):1052-1060. PubMed ID: 35764271
[TBL] [Abstract][Full Text] [Related]
31. Immune Checkpoint Blockade Therapy in Patients With Colorectal Cancer Harboring Microsatellite Instability/Mismatch Repair Deficiency in 2022.
André T; Cohen R; Salem ME
Am Soc Clin Oncol Educ Book; 2022 Apr; 42():1-9. PubMed ID: 35471834
[TBL] [Abstract][Full Text] [Related]
32. Sarcoid-like Reaction Discovered on EBUS-TBNA of Intrathoracic Lymph Nodes During Immunotherapy for Metastatic Melanoma.
Frohlich M; Wang H; Sakr L
J Immunother; 2020; 43(2):75-78. PubMed ID: 31567703
[TBL] [Abstract][Full Text] [Related]
33. Sarcoidosis-Like Reactions Induced by Checkpoint Inhibitors.
Gkiozos I; Kopitopoulou A; Kalkanis A; Vamvakaris IN; Judson MA; Syrigos KN
J Thorac Oncol; 2018 Aug; 13(8):1076-1082. PubMed ID: 29763666
[TBL] [Abstract][Full Text] [Related]
34. Pseudoprogression in patients treated with immune checkpoint inhibitors for microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer.
Colle R; Radzik A; Cohen R; Pellat A; Lopez-Tabada D; Cachanado M; Duval A; Svrcek M; Menu Y; André T
Eur J Cancer; 2021 Feb; 144():9-16. PubMed ID: 33316636
[TBL] [Abstract][Full Text] [Related]
35. Neoadjuvant Immunotherapy for MSI-H/dMMR Locally Advanced Colorectal Cancer: New Strategies and Unveiled Opportunities.
Zhang X; Wu T; Cai X; Dong J; Xia C; Zhou Y; Ding R; Yang R; Tan J; Zhang L; Zhang Y; Wang Y; Dong C; Li Y
Front Immunol; 2022; 13():795972. PubMed ID: 35371084
[TBL] [Abstract][Full Text] [Related]
36. Sarcoidosis-like reaction during palbociclib treatment for metastatic breast cancer: A case report.
Stoffaës L; Dumazet A; Deslee G; Mohammad Muttaqi Z; Didier K; Botsen D
Breast J; 2020 Jun; 26(6):1239-1241. PubMed ID: 32275106
[TBL] [Abstract][Full Text] [Related]
37. Immunotherapy-Induced Airway Disease: A New Pattern of Lung Toxicity of Immune Checkpoint Inhibitors.
Mitropoulou G; Daccord C; Sauty A; Pasche A; Egger B; Aedo Lopez V; Letovanec I; Beigelman-Aubry C; Nicod LP; Lazor R
Respiration; 2020; 99(2):181-186. PubMed ID: 31914436
[TBL] [Abstract][Full Text] [Related]
38. Unanticipated pathological clearance in two cases of clinical T4b dMMR/MSI-h advanced colorectal cancer: the potential of immune checkpoint inhibitors despite positive positron-emission tomography results.
Nakamura D; Yanagita T; Fujii Y; Watanabe K; Suzuki T; Ushigome H; Nishigaki R; Sugimura N; Tanaka M; Ogawa R; Takahashi H; Shimura T; Hotta Y; Matsuo Y; Kondo M; Furukawa-Hibi Y; Takiguchi S
Surg Case Rep; 2024 May; 10(1):105. PubMed ID: 38691233
[TBL] [Abstract][Full Text] [Related]
39. Immunotherapy and metastatic colorectal cancers with microsatellite instability or mismatch repair deficiency.
Cohen R; Pellat A; Boussion H; Svrcek M; Lopez-Trabada D; Trouilloud I; Afchain P; André T
Bull Cancer; 2019 Feb; 106(2):137-142. PubMed ID: 30327191
[TBL] [Abstract][Full Text] [Related]
40. Immunotherapy-Induced Sarcoid-Like Reaction: A Shrewd Imitator.
Yasin H; Yadala V; Khan NAJ; Graffeo V; Denning K; Lebowicz Y
J Investig Med High Impact Case Rep; 2021; 9():23247096211009400. PubMed ID: 33847154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
